Richard D Lawless, Colin D McKnight, Kristin P O’Grady, Anna JE Combes, Baxter P Rogers, Atlee A Witt, Mereze Visagie, Delaney C Houston, Logan E Prock, Francesca R Bagnato, Seth A Smith
{"title":"Detecting macromolecular differences of the CSF in low disability multiple sclerosis using quantitative MT MRI at 3T","authors":"Richard D Lawless, Colin D McKnight, Kristin P O’Grady, Anna JE Combes, Baxter P Rogers, Atlee A Witt, Mereze Visagie, Delaney C Houston, Logan E Prock, Francesca R Bagnato, Seth A Smith","doi":"10.1177/20552173231211396","DOIUrl":null,"url":null,"abstract":"Background Imaging investigation of cerebrospinal fluid (CSF) in multiple sclerosis (MS) is understudied. Development of noninvasive methods to detect pathological CSF changes would have a profound effect on MS diagnosis and would offer insight into MS pathophysiology and mechanisms of neurological impairment. Objective We propose magnetization transfer (MT) MRI as a tool to detect macromolecular changes in spinal CSF. Methods MT and quantitative MT (qMT) data were acquired in the cervical region in 27 people with relapsing-remitting multiple sclerosis (pwRRMS) and 38 age and sex-matched healthy controls (HCs). MT ratio (MTR), the B 1 , B 0 , and R 1 corrected qMT-derived pool size ratio (PSR) were quantified in the spinal cord and CSF of each group. Results Both CSF MTR and CSF qMT-derived PSR were significantly increased in pwRRMS compared to HC ( p = 0.027 and p = 0.020, respectively). CSF PSR of pwRRMS was correlated to Expanded Disability Status Scale Scores ( p = 0.045, R = 0.352). Conclusion Our findings demonstrate increased CSF macromolecular content in pwRRMS and link CSF macromolecular content with clinical impairment. This highlights the potential role of CSF in processing products of demyelination.","PeriodicalId":18961,"journal":{"name":"Multiple Sclerosis Journal - Experimental, Translational and Clinical","volume":"60 1","pages":"0"},"PeriodicalIF":2.5000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis Journal - Experimental, Translational and Clinical","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20552173231211396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background Imaging investigation of cerebrospinal fluid (CSF) in multiple sclerosis (MS) is understudied. Development of noninvasive methods to detect pathological CSF changes would have a profound effect on MS diagnosis and would offer insight into MS pathophysiology and mechanisms of neurological impairment. Objective We propose magnetization transfer (MT) MRI as a tool to detect macromolecular changes in spinal CSF. Methods MT and quantitative MT (qMT) data were acquired in the cervical region in 27 people with relapsing-remitting multiple sclerosis (pwRRMS) and 38 age and sex-matched healthy controls (HCs). MT ratio (MTR), the B 1 , B 0 , and R 1 corrected qMT-derived pool size ratio (PSR) were quantified in the spinal cord and CSF of each group. Results Both CSF MTR and CSF qMT-derived PSR were significantly increased in pwRRMS compared to HC ( p = 0.027 and p = 0.020, respectively). CSF PSR of pwRRMS was correlated to Expanded Disability Status Scale Scores ( p = 0.045, R = 0.352). Conclusion Our findings demonstrate increased CSF macromolecular content in pwRRMS and link CSF macromolecular content with clinical impairment. This highlights the potential role of CSF in processing products of demyelination.